APA (7th ed.) Citation

Rundquist, S., Sachs, M. C., Eriksson, C., Olén, O., Montgomery, S., & Halfvarson, J. (2021). Editorial: Anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply. Alimentary Pharmacology & Therapeutics, 53(5), 642. https://doi.org/10.1111/apt.16241

Chicago Style (17th ed.) Citation

Rundquist, Sara, Michael C. Sachs, Carl Eriksson, Ola Olén, Scott Montgomery, and Jonas Halfvarson. "Editorial: Anti‐TNF Agents Against Vedolizumab as a Second‐line Treatment? Not Surprising Tie Game—authors' Reply." Alimentary Pharmacology & Therapeutics 53, no. 5 (2021): 642. https://doi.org/10.1111/apt.16241.

MLA (9th ed.) Citation

Rundquist, Sara, et al. "Editorial: Anti‐TNF Agents Against Vedolizumab as a Second‐line Treatment? Not Surprising Tie Game—authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 53, no. 5, 2021, p. 642, https://doi.org/10.1111/apt.16241.